Mira Pharmaceuticals Inc (MIRA)
1.17
+0.10
(+9.35%)
USD |
NASDAQ |
Sep 27, 16:00
1.12
-0.05
(-4.27%)
After-Hours: 20:00
Mira Pharmaceuticals Cash from Operations (Quarterly): -0.8639M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.8639M |
| March 31, 2024 | -1.050M |
| December 31, 2023 | -1.035M |
| September 30, 2023 | -1.761M |
| June 30, 2023 | -0.6608M |
| Date | Value |
|---|---|
| March 31, 2023 | -1.075M |
| December 31, 2022 | -0.9754M |
| September 30, 2022 | -1.315M |
| June 30, 2022 | -1.272M |
| March 31, 2022 | -2.043M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-2.043M
Minimum
Mar 2022
-0.6608M
Maximum
Jun 2023
-1.205M
Average
-1.062M
Median
Cash from Operations (Quarterly) Benchmarks
| Viking Therapeutics Inc | -28.51M |
| Perspective Therapeutics Inc | -8.902M |
| Alaunos Therapeutics Inc | -1.681M |
| MEI Pharma Inc | -18.00M |
| Oragenics Inc | -1.544M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 0.159M |
| Free Cash Flow | -4.710M |
| Free Cash Flow Per Share (Quarterly) | -0.0584 |
| Free Cash Flow Yield | -25.60% |